AR and temporal arteritis: In this study, we first discovered that Ar expression might be a new prognostic biomarker and an important gatekeeper in multiple treatment modalities for patients with GCa; thus, Ar has potential to serve as a targeting agent to develop medications to fulfil unmet medical needs.